Single vs Multi-Inhalers for COPD Treatment
Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
Recruiting
N/A
Interventional Study
Copd
Adherence, Medication
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 300 (estimated)
- Sponsor
- Franciscus Gasthuis · Other
Who this trial is looking for
This trial is looking for adults with chronic obstructive pulmonary disease (COPD) to see if using one inhaler is better than using multiple inhalers. Participants will also explore if digital support helps with their treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 40 years old or older
- I have been diagnosed with COPD for at least 1 year
- My doctor says I need triple therapy for my COPD
- I own a mobile device that can use an app and connect to the internet
- I can give written consent to participate
- I am a current or ex-smoker
You may not be able to join if
- I cannot follow the study procedures
- I don't understand Dutch well enough to use the app
- I have asthma as my main disease
- I have used a COPD e-health application in the past six months
- I am using other treatments that could interfere with the study drugs
- I use nebulized bronchodilators
- I am pregnant or breastfeeding
- I cannot complete the questionnaires
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
TRICOLON is an investigator initiated, prospective, interventional, open-label, randomized, real-world, multi-centre, 3-arms study in the Netherlands. The primary objective is to investigate in COPD patients if single-inhaler triple therapy (SITT) is superior to multi-inhaler triple therapy (MITT) in terms of adherence to inhaled corticosteroids (ICS) therapy and to investigate if SITT with e-heal…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinical diagnosis of COPD for at least 1 year before the screening visit
* Aged 40 years and older
* An indication for triple therapy according to the treating physician (following the GOLD guideline 2021(2)). Could be step-up from dual therapy or currently receiving triple t…
Contacts